Abstract:ABSTRACT The host innate immune system’s defense against viral infections depends heavily on type I interferon (IFN-I) production. Research into the mechanisms of virus-host interactions is essential for developing novel antiviral therapies. In this study, we compared the effect of the five members of the microRNA-200 (miR-200) family on IFN-I production during viral infection and found that miR-200b-3p displayed the most pronounced regulatory effect. During viral infection, we discovered that the transcriptional level of microRNA-200b-3p (miR-200b-3p) increased with the infection of influenza virus (IAV) and vesicular stomatitis virus (VSV), and miR-200b-3p production was modulated by the activation of the ERK and p38 pathways. We identified cAMP response element binding protein (CREB) as a novel transcription factor that binds to the miR-200b-3p promoter. MiR-200b-3p reduces NF-κB and IRF3-mediated IFN-I production by targeting the 3′ untranslated region (3′ UTR) of TBK1 mRNA. Applying miR-200b-3p inhibitor enhances IFN-I production in IAV and VSV-infected mouse models, thus inhibiting viral replication and improving mouse survival ratio. Importantly, in addition to IAV and VSV, miR-200b-3p inhibitors exhibited potent antiviral effects against multiple pathogenic viruses threatening human health worldwide. Overall, our study suggests that miR-200b-3p might be a potential therapeutic target for broad-spectrum antiviral therapy. IMPORTANCE The innate immune response mediated by type I interferon (IFN-I) is essential for controlling viral replication. MicroRNAs (miRNAs) have been found to regulate the IFN signaling pathway. In this study, we describe a novel function of miRNA-200b-3p in negatively regulating IFN-I production during viral infection. miRNA-200b-3p was upregulated by the MAPK pathway activated by IAV and VSV infection. The binding of miRNA-200b-3p to the 3′ UTR of TBK1 mRNA reduced IFN-I activation mediated by IRF3 and NF-κB. Application of miR-200b-3p inhibitors exhibited potent antiviral effects against multiple RNA and DNA viruses. These results provide fresh insight into understanding the impact of miRNAs on host-virus interactions and reveal a potential therapeutic target for common antiviral intervention.

Mir-29A is a Negative Regulator of Influenza Virus Infection Through Targeting of the Frizzled 5 Receptor

Mir‐193b Represses Influenza A Virus Infection by Inhibiting Wnt/β‐catenin Signalling

NMI Facilitates Influenza A Virus Infection by Promoting Degradation of IRF7 Through TRIM21.

Up-regulation of microRNA-203 in influenza A virus infection inhibits viral replication by targeting DR1.

Human microRNA‐30 inhibits influenza virus infection by suppressing the expression of SOCS1, SOCS3, and NEDD4

Identification of cellular microRNA miR-188-3p with broad-spectrum anti-influenza A virus activity

MicroRNA-9-1 Attenuates Influenza A Virus Replication Via Targeting Tankyrase 1.

The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-[gamma]

Critical Role of Micrornas in Host and Influenza A (H1N1) Virus Interactions.

LncRNA LINC02574 Inhibits Influenza A Virus Replication by Positively Regulating the Innate Immune Response

Microrna-206 Inhibits Influenza A Virus Replication By Targeting Tankyrase 2

MicroRNA-200c-targeted contactin 1 facilitates the replication of influenza A virus by accelerating the degradation of MAVS

Therapeutic role of miR-19a/b protection from influenza virus infection in patients with coronary heart disease

MicroRNA-33/33* Inhibit the Activation of MAVS Through AMPK in Antiviral Innate Immunity

CircRNA_0050463 promotes influenza A virus replication by sponging miR-33b-5p to regulate EEF1A1

MicroRNA let-7 Suppresses Influenza A Virus Infection by Targeting RPS16 and Enhancing Type I Interferon Response

The Interferon-Induced Protein with Tetratricopeptide Repeats Repress Influenza Virus Infection by Inhibiting Viral RNA Synthesis

p21 restricts influenza A virus by perturbing the viral polymerase complex and upregulating type I interferon signaling

Inhibition of miR-200b-3p confers broad-spectrum resistance to viral infection by targeting TBK1

Downregulation of Mir-218 by Porcine Reproductive and Respiratory Syndrome Virus Facilitates Viral Replication Via Inhibition of Type I Interferon Responses

microRNA-guided immunity against respiratory virus infection in human and mouse lung cells